WayneL.PollMD

CEO, Mirabilis Medical, Inc, Seattle WA 2019-current;; CEO and founder, Minimally Invasive Devices, Inc. 2007-2016

Dr. Poll is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Massachusetts General Hospital/Harvard Medical SchoolResidency, Urology, 1986 - 1986
Massachusetts General Hospital/Harvard Medical SchoolResidency, Urology, 1984 - 1984
University of ConnecticutResidency, Surgery, 1981 - 1983
Vanderbilt University School of MedicineClass of 1981
Duke UniversityA.B., Chemistry, Summa Cum Laude, 1977

Robotic FloShieldTM 1st Place Excellence in Surgical Products Award 2014
Recipient of R&D Healthcare Award Columbus CEO Magazine, 2013
First Place, Start-Up of the Year, TechColumbus Innovation Awards Minimally Invasive Devices, Inc., 2011
First Place, Strategic Capital Fund Raising, TechColumbus Innovation Awards Minimally Invasive Devices, Inc., 2011
First Place, CEO of the Year TechColumbus Innovation Awards, 2011
FloShieldTM winds First Place among 54 new medical devices Surgical Products Magazine, 2009
Innovation Award Finalist, Start-Up Business of the Year 2009
Recognition as Superstar in Research and Development Columbus CEO magazine, 2008
Innovation Award Winner, Inventor of the Year 2008
Business First Award for Top Health Care Innovator 2007
First Place, Business Plan Competition Ohio State University, 2006
Innovation Award Finalist, Inventor of the Year 2005-2006
Docs Rate Docs, Columbus Dispatch award as Columbus, OH outstanding Urologist 2004
Phi Beta Kappa 1976
Chemical Abstracts Award
Join now to see all

PubMed

103 citations
Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer
Tomasz M. Beer, Guy T. Bernstein, John M. Corman, L. Michael Glode, Simon J. Hall, Wayne L. Poll, Paul F. Schellhammer, Lori A. Jones, Yi Xu, Jelle Kylstra, Mark W. Fr...> ;Clinical Cancer Research. 2011 Jul 1
4 citations
Robotic Radical Prostatectomy at a Teaching Community Hospital: Outcomes and Safety
Julianna Padavano, Lynn E.T. Shaffer, Elizabeth A. Fannin, John Burgers, Wayne Poll, Eric S. Ward, Kevin Banks, Jeffrey G. Bell> ;JSLS. 2011 Apr 1
1 citations
Derision is the sweet spot of adoption: unleashing disruptive growth.
Wayne Poll> ;Hospital Topics. 2011 Feb 24

Other

Personal View: How Suspending the Device Tax Is Driving InnovationJune 5th, 2016